052sek
1,2 %
Date:2025-07-16Time:18:00:00Latest report:Q1-2025List:First NorthTicker:SPRINT
Market Cap:55 msekEnterprise Value:36 msekNet Sales:61,9 msekEarnings:-20,8 msekEmployees:0ISIN:SE0006343745

Ratios

10-year key figure history for Sprint Bioscience turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Sprint Bioscience with index and moving average MA50 and MA200.

Stockprice:0,52
MA50:0,48
MA200:1,17
Price/MA200:-55,6 %
RSI (14):54,9
Price/MA50:8,4 %

Description

Sprint Bioscience is a research company. The company develops drug candidates that can fight cancer individually or in combination with other drugs. The company has a portfolio of projects that are focused on attacking parts of the processes of cancer cells. The business model is based on a project portfolio and developing projects in parallel in the preclinical phase and then entering into licensing agreements with the global pharmaceutical industry. The company is headquartered in Huddinge.

Biotechnology